|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
17 August 2020 |
|
Main ID: |
IRCT20100420003760N4 |
|
Date of registration:
|
2020-07-29 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Compare the effectiveness of betamethasone and lavender and peppermint in reducing the severity of symptoms in patients with eczema and psoriasis
|
|
Scientific title:
|
Compare the effectiveness of betamethasone and lavender and peppermint in reducing the severity of symptoms in patients with eczema and psoriasis |
|
Date of first enrolment:
|
2017-01-19 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://en.irct.ir/trial/3869 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Not randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Blinding description: Patients, physicians, questioners, and data analysts associated with the study outcome are unaware of the codes associated with each formulation. The researcher is not involved in this process. The drugs were placed in envelopes and given to the doctor.
|
|
Phase:
|
2
|
|
|
Countries of recruitment
|
|
Iran (Islamic Republic of)
| | | | | | | |
|
Contacts
|
|
Name:
|
Marzieh Rashidipour
|
|
Address:
|
Lorestan University of Medical Sciences, Anooshirvan Rezaei Square, Khorramabad, Lorestan, Iran.
6814989468
Khorramabad
Iran (Islamic Republic of) |
|
Telephone:
|
+98 66 3320 4005 |
|
Email:
|
m_rashidi80@yahoo.com |
|
Affiliation:
|
Lorestan University of Medical Sciences |
|
|
Name:
|
Marzieh Rashidipour
|
|
Address:
|
Lorestan University of Medical Sciences, Anooshirvan Rezaei Square, Khorramabad, Lorestan, Iran.
6814989468
Khorramabad
Iran (Islamic Republic of) |
|
Telephone:
|
+98 66 3312 0172 |
|
Email:
|
m_rashidi80@yahoo.com |
|
Affiliation:
|
Lorestan University of Medical Sciences, Anooshirvan Rezaei Square, Khorramabad, Lorestan, Iran. |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Inclusion criteria: The study population of men and women over the age of 10 with eczema or psoriasis who have been referred to the nomadic hospital since the beginning of the fall of 2016 for one year.
Exclusion criteria: Patients who have had a corticosteroid injection or have taken other oral or topical medications will be excluded.
Age minimum:
10 years
Age maximum:
90 years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
L40.9, L85
|
Condition 1: eczema and psoriasis. Condition 2: Psoriasis.
Dry skin dermatitis, Psoriasis, unspecified
Dry skin dermatitis, Psoriasis, unspecified
|
|
Intervention(s)
|
|
Intervention 1: Intervention group: receive the essential oil of Lavendula ooficinalis 3 % b.i.d Up to two weeks. Intervention 2: Intervention group: receive the essential oil of Lavendula ooficinalis 5 % b.i.d Up to two weeks. Intervention 3: Intervention group: receive the essential oil of Lavendula ooficinalis 7 % b.i.d Up to two weeks. Intervention 4: Control group: receive Eucerin b.i.d Up to two weeks. Intervention 5: Control group: receive Betamethasone b.i.d Up to two weeks. Intervention 6: Intervention group: receive the essential oil of Menthe piperita 5% b.i.d Up to two weeks. Intervention 7: Intervention group: receive the essential oil of Menthe piperita 7 % b.i.d Up to two weeks. Intervention 8: Intervention group: receive the essential oil of Menthe piperita 3% b.i.d Up to two weeks.
|
|
Primary Outcome(s)
|
|
Painful. Timepoint: 0,7,14. Method of measurement: Questionnaire.
|
|
Skin lesions. Timepoint: 0,7,14. Method of measurement: Questionnaire.
|
|
Itching. Timepoint: 0,7,14. Method of measurement: Questionnaire.
|
|
Scaly. Timepoint: 0,7,14. Method of measurement: Questionnaire.
|
|
Swelling. Timepoint: 0,7,14. Method of measurement: Questionnaire.
|
|
Redness of the skin. Timepoint: 0,7,14. Method of measurement: Questionnaire.
|
|
Secondary Outcome(s)
|
|
Skin irritation. Timepoint: Days 1,7,14. Method of measurement: Questionnaire.
|
|
Source(s) of Monetary Support
|
|
Khoram-Abad University of Medical Sciences
|
|
Ethics review
|
Status: Approved
Approval date: 26/12/2016
Contact:
Lorestan University of Medical Sciences Ethics Committee
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|